Wildcat Capital Management Q2 2026 Portfolio Activity: Significant Increase in Chime Finl Inc (CHYM)

Wildcat Capital Management, Llc held an impressively concentrated portfolio as of June 30, 2026. The fund's holdings are dominated by positions within the Industrials and Healthcare sectors.

Key Changes in Q2

The most notable change during this quarter was a significant increase in shares held for CHIME FINL INC (CHYM). According to the filing, Chime Finl Inc experienced a 100% jump in its holdings compared to the previous quarter.

Unchanged Major Holdings

The fund's largest holding, FRONTIER GROUP HLDGS INC (ULCC), maintained an unchanged position at Ulcc, representing a massive 97.13% allocation to the portfolio.

Smaller Position Growth

In addition, ALLOGENE THERAPEUTICS INC (ALLO) held steady at its current level in the Allo position.

No Sells or Reduces Observed

The data indicates no sales or reductions were observed by Wildcat Capital Management during this quarter. The fund did not exit any positions, and there was no activity reported for ALLO or ULCC.

Portfolio Concentration Highlights

This filing confirms the portfolio's extreme concentration, with only three distinct holdings tracked here: Ulcc (97.13%), Allo (2.66%), and Chym (0.21%). The top two holdings alone account for nearly all of Wildcat Capital Management's assets.

For detailed information on Wildcat Capital Management, Llc's investment strategy and portfolio performance, please visit their profile at InsiderSet.